Page last updated: 2024-10-30

mafenide and Infection, Postoperative Wound

mafenide has been researched along with Infection, Postoperative Wound in 3 studies

Mafenide: A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.

Research Excerpts

ExcerptRelevanceReference
"Large TBSA burns have a deficiency of skin graft donor sites necessitating meshed skin autografts, cultured epithelial autografts or biosynthetic skin substitutes."1.30The efficacy of 5% Sulfamylon solution for the treatment of contaminated explanted human meshed skin grafts. ( Hill, DP; Ko, F; Maggi, SP; Robson, MC; Smith, PD; Soler, PM, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pendleton, RA1
Holmes, JH1
CERNEA, R1
Maggi, SP1
Soler, PM1
Smith, PD1
Hill, DP1
Ko, F1
Robson, MC1

Trials

1 trial available for mafenide and Infection, Postoperative Wound

ArticleYear
Systemic absorption of amphotericin B with topical 5% mafenide acetate/amphotericin B solution for grafted burn wounds: is it clinically relevant?
    Burns : journal of the International Society for Burn Injuries, 2010, Volume: 36, Issue:1

    Topics: Administration, Cutaneous; Amphotericin B; Anti-Infective Agents; Anti-Infective Agents, Local; Burn

2010

Other Studies

2 other studies available for mafenide and Infection, Postoperative Wound

ArticleYear
[Practical innovation in local sulfonamide application with aseptorid-marbadal-vulnoplast].
    Therapie der Gegenwart, 1953, Volume: 92, Issue:4

    Topics: Bandages; Mafenide; Sulfanilamide; Sulfanilamides; Sulfonamides; Surgical Wound Infection

1953
The efficacy of 5% Sulfamylon solution for the treatment of contaminated explanted human meshed skin grafts.
    Burns : journal of the International Society for Burn Injuries, 1999, Volume: 25, Issue:3

    Topics: Animals; Anti-Infective Agents, Local; Burns; Disease Models, Animal; Graft Survival; Humans; Mafeni

1999